Mimura S, Morishita A, Oura K, Takuma K, Nakahara M, Tadokoro T
Int J Mol Sci. 2025; 26(2).
PMID: 39859504
PMC: 11766161.
DOI: 10.3390/ijms26020790.
Qiu Q, Li C, Zhao X, Yang M, Ding S, Liang H
CNS Neurosci Ther. 2024; 30(11):e70127.
PMID: 39592913
PMC: 11598744.
DOI: 10.1111/cns.70127.
Sasaki T, Oyama M, Kubota M, Isshiki Y, Takeuchi T, Tanaka T
Int J Mol Sci. 2024; 25(16).
PMID: 39201412
PMC: 11354322.
DOI: 10.3390/ijms25168725.
Huang Z, Liu X, Huang S, Lu F
Parasit Vectors. 2024; 17(1):232.
PMID: 38769548
PMC: 11106894.
DOI: 10.1186/s13071-024-06314-5.
Yuksel Aytekin M, Kahve A, Ekinci R, Sakalli Nural A, Cakmak I, Ayaz Nayci N
Braz J Psychiatry. 2024; 46:e20243535.
PMID: 38767861
PMC: 11744267.
DOI: 10.47626/1516-4446-2024-3535.
Galectin-3 impairs calcium transients and β-cell function.
Jiang Q, Zhao Q, Chen Y, Ma C, Peng X, Wu X
Nat Commun. 2024; 15(1):3682.
PMID: 38693121
PMC: 11063191.
DOI: 10.1038/s41467-024-47959-1.
Serum Galectin-1, Galectin-9, and YKL-40 levels in bipolar disorder and their relationship with cognitive functions.
Selahaddin E, Bahadir D, Sengul S, Seyithan T, Hasan U, Gulcin E
Brain Behav. 2024; 14(2):e3421.
PMID: 38346720
PMC: 10861353.
DOI: 10.1002/brb3.3421.
The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target.
Zhou Z, Feng Z, Sun X, Wang Y, Dou G
Int J Mol Sci. 2023; 24(21).
PMID: 37958500
PMC: 10649114.
DOI: 10.3390/ijms242115516.
Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1.
Rudjord-Levann A, Ye Z, Hafkenscheid L, Horn S, Wiegertjes R, Nielsen M
iScience. 2023; 26(7):106984.
PMID: 37534161
PMC: 10391608.
DOI: 10.1016/j.isci.2023.106984.
Inhibition of LPS-Induced Inflammatory Response of Oral Mesenchymal Stem Cells in the Presence of Galectin-3.
Paganelli A, Diomede F, Marconi G, Pizzicannella J, Rajan T, Trubiani O
Biomedicines. 2023; 11(6).
PMID: 37371614
PMC: 10295455.
DOI: 10.3390/biomedicines11061519.
Selectively Modified Lactose and -Acetyllactosamine Analogs at Three Key Positions to Afford Effective Galectin-3 Ligands.
Abdullayev S, Kadav P, Bandyopadhyay P, Medrano F, Rabinovich G, Dam T
Int J Mol Sci. 2023; 24(4).
PMID: 36835132
PMC: 9962200.
DOI: 10.3390/ijms24043718.
Upregulation of galectin-3 in influenza A virus infection promotes viral RNA synthesis through its association with viral PA protein.
Yang M, Chen Y, Wang C, Chong H, Chung N, Leu C
J Biomed Sci. 2023; 30(1):14.
PMID: 36823664
PMC: 9948428.
DOI: 10.1186/s12929-023-00901-x.
Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy.
Liu D, Zhu H, Li C
Biomark Res. 2023; 11(1):22.
PMID: 36814341
PMC: 9945697.
DOI: 10.1186/s40364-023-00466-9.
The multifaceted role of MUC1 in tumor therapy resistance.
Jin W, Zhang M, Dong C, Huang L, Luo Q
Clin Exp Med. 2022; 23(5):1441-1474.
PMID: 36564679
DOI: 10.1007/s10238-022-00978-y.
NMR Investigation of Protein-Carbohydrate Interactions: The Recognition of Glycans by Galectins Engineered with Fluorotryptophan Residues.
Lete M, Franconetti A, Bertuzzi S, Delgado S, Azkargorta M, Elortza F
Chemistry. 2022; 29(5):e202202208.
PMID: 36343278
PMC: 10107428.
DOI: 10.1002/chem.202202208.
Galectins-Potential Therapeutic Targets for Neurodegenerative Disorders.
Chaudhary S, Chaudhary S, Rawat S, Kulkarni A, Bilgrami A, Perveen A
Int J Mol Sci. 2022; 23(19).
PMID: 36232314
PMC: 9569834.
DOI: 10.3390/ijms231911012.
Galectin-3 Is a Crucial Immunological Disease Marker in Patients with Fungal Keratitis.
Xiao Y, Yang J, Fu Z, He D, Li N, Yuan J
Dis Markers. 2022; 2022:1380560.
PMID: 35845133
PMC: 9286934.
DOI: 10.1155/2022/1380560.
Inhibition of Galectin-3 Impairs Antifungal Immune Response in Fungal Keratitis.
Xiao Y, Yang J, Fu Z, Xiong Z, Zhang C, He D
Dis Markers. 2022; 2022:8316004.
PMID: 35437453
PMC: 9013289.
DOI: 10.1155/2022/8316004.
Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target.
Boutin L, Depret F, Gayat E, Legrand M, Chadjichristos C
Int J Mol Sci. 2022; 23(6).
PMID: 35328545
PMC: 8952808.
DOI: 10.3390/ijms23063124.
The role of galectins‑1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review).
Mielczarek-Palacz A, Kondera-Anasz Z, Smycz-Kubanska M, Englisz A, Janusz A, Krolewska-Daszczynska P
Mol Med Rep. 2022; 25(5).
PMID: 35293602
PMC: 8941520.
DOI: 10.3892/mmr.2022.12682.